Organon (OGN) Current Assets (2020 - 2026)

Organon has reported Current Assets for 7 years, with the latest figure at $5.1 billion in Q2 2026.

• On a quarterly basis, Current Assets rose 10.68% year-over-year to $5.1 billion in Q2 2026; TTM through Jun 2026 was $5.1 billion, a 10.68% increase from a year earlier, with the FY2025 full-year figure at $4.4 billion, changed 0.09% from the prior year.
• Current Assets was $5.1 billion for Q2 2026 at Organon, up from $4.9 billion in the prior quarter.
• The five-year high for Current Assets was $5.1 billion in Q2 2026, with the low at $3.6 billion in Q3 2022.
• Average Current Assets over 5 years is $4.3 billion, with a median of $4.4 billion recorded in 2024.
• The largest YoY upside for Current Assets was 24.92% in 2022 against a maximum downside of 17.02% in 2022.
• Over 5 years, Current Assets stood at $3.9 billion in 2022, then rose by 14.68% to $4.5 billion in 2023, then declined by 3.55% to $4.3 billion in 2024, then increased by 0.09% to $4.4 billion in 2025, then climbed by 17.44% to $5.1 billion in 2026.
• The last three Current Assets figures came in at $5.1 billion (Q2 2026), $4.9 billion (Q1 2026), and $4.4 billion (Q4 2025), per Business Quant data.